Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 2;23(4):128.
doi: 10.31083/j.rcm2304128. eCollection 2022 Apr.

Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications

Philipp von Gottberg  1 , Alexandru Cimpoca  1 , Christina Wendl  2 , José E Cohen  3 , Ulrich Speck  4 , Hans Henkes  1   5
Affiliations

Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications

Philipp von Gottberg et al. Rev Cardiovasc Med. .

Abstract

Background: Drug-coated balloons (DCB) are an established tool in the prevention and treatment of coronary and peripheral artery restenosis. The underlying effects of restenosis resemble those in the neurovascular field, yet data on the use of DCB in cervical and intracranial arteries is rare.

Methods: Medline, and international and major national guidelines and recommendations were systematically searched for data addressing the use of DCB in the neurovascular setting.

Results: Of the 1448 relevant records found in Medline, 166 publications were considered for this review.

Conclusions: Data on the use of DCB in the neurovascular setting show a possible benefit over preceding alternatives, such as self-expanding stents, and balloon-mounted or drug-eluting stents. Nonetheless, the role of DCB remains under-researched, and publications remain lacking.

Keywords: arterial stenosis; carotid artery stenosis; drug-coated balloons; intracranial atherosclerotic stenosis; neurointerventional; neurovascular; paclitaxel; percutaneous transluminal angioplasty; stroke.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Bonati LH, Dobson J, Featherstone RL, Ederle J, van der Worp HB, de Borst GJ, et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. The Lancet . 2015;385:529–538. - PMC - PubMed
    1. Brott TG, Hobson RW, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. The New England Journal of Medicine . 2010;363:11–23. - PMC - PubMed
    1. Halliday A, Bulbulia R, Bonati LH, Chester J, Cradduck-Bamford A, Peto R, et al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. The Lancet . 2021;398:1065–1073. - PMC - PubMed
    1. Featherstone RL, Dobson J, Ederle J, Doig D, Bonati LH, Morris S, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): a randomised controlled trial with cost-effectiveness analysis. Health Technology Assessment . 2016;20:1–94. - PMC - PubMed
    1. Spadaccio C, Benedetto U. Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease. Annals of Cardiothoracic Surgery . 2018:506–515. - PMC - PubMed

Publication types

LinkOut - more resources